Bone mineral density increases during long-term growth hormone treatment but decreases after cessation of treatment in young adults born small for gestational age, researchers from The Netherlands report. ...
Data on patients who received recombinant human growth hormone (r-hGH) as children “do not generally support a carcinogenic effect of r-hGH” - although the researchers did see increased risks in certain...
European countries with more restrictive reimbursement for growth hormone use in pediatric end-stage renal disease end up with shorter children, according to a new report.
